Two Sigma Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Two Sigma Advisers’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-43,000	Closed	-$2.2M	–	2440
2014 Q3	$2.2M	Buy	43,000 +32,000	+291%	+$1.6M	0.02%	781
2014 Q2	$534K	Buy	11,000 +6,000	+120%	+$296K	﹤0.01%	1634
2014 Q1	$260K	Sell	5,000 -30,500	-86%	-$1.62M	﹤0.01%	1956
2013 Q4	$1.89M	Sell	35,500 -13,400	-27%	-$683K	0.02%	775
2013 Q3	$2.26M	Buy	48,900 +33,900	+226%	+$1.49M	0.03%	582
2013 Q2	$670K	Buy	+15,000	New	+$651K	0.01%	1124

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Advisers's BMY Position: Q1 2026 in Review

Two Sigma Advisers sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 8,270,200 shares — an estimated $446M sold.

Two Sigma Advisers first reported a position in BMY in Q3 2013 and held it in 43 quarters. The position peaked at $494M in Q3 2024. 2,538 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Two Sigma Advisers reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 8,270,200 Bristol-Myers Squibb shares in Q1 2026, an estimated $446M.
Two Sigma Advisers first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 43 quarters.
Two Sigma Advisers's Bristol-Myers Squibb position peaked at $494M in Q3 2024.
2,538 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.